A Study to Assess the Abuse Potential of Intranasal Cebranopadol
Clinical trial NCT06453265 · COMPLETED
Trial details
- NCT number
- NCT06453265
- Sponsor
- Tris Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-28
- Primary completion
- 2024-11-06
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.